Indicated for active immunization of infants and children aged 2 months to under 6 years for the prevention of disease caused by Enterovirus 71 (EV71) infection. 藥理：EnteVax (Enterovirus 71 vaccine) induces neutralizing antibodies against Enterovirus 71, providing active immunization to prevent diseases caused by Enterovirus 71 infection.

Vaccines

This vaccine is contraindicated in: Individuals who have experienced a severe allergic reaction following a previous dose of this vaccine. Individuals with a known hypersensitivity to any component of the vaccine (see sections on "Active Ingredients" and "Excipients") or to any residual trace elements such as formaldehyde.

Not applicable. This vaccine is indicated for infants and children aged 2 months to under 6 years. There are currently no data on the use of this vaccine in pregnant women.

Not applicable. This vaccine is indicated for infants and children aged 2 months to under 6 years. There are currently no data on the use of this vaccine in breastfeeding women.

Common adverse reactions include injection site erythema and swelling, injection site pain, diarrhea, decreased appetite, fatigue, and pyrexia.

Method of Administration: The vaccine should be administered via intramuscular injection into the deltoid muscle of the upper arm; for infants and young children, the anterolateral aspect of the thigh is the preferred site. Dosing Schedule: Each dose is 0.5 mL. The primary series consists of two doses administered at a 28-day interval. Booster Dose: The necessity of a booster dose for this vaccine has not yet been established.

Store at 2 to 8°C (36 to 46°F). Protect from light. Keep the pre-filled syringe in the outer carton until use.